ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE

Show other versions (1)

<p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and...

Full description

Bibliographic Details
Main Authors: S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
Online Access:http://klinitsist.abvpress.ru/index.php/Klin/article/view/125
id doaj-3eda1d3b051444adb65f08a92e6ffc0b
record_format Article
spelling doaj-3eda1d3b051444adb65f08a92e6ffc0b2020-11-25T01:07:44ZrusABV-pressKlinicist1818-83382014-07-01527279140ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCES. Yu. Martsevich0N. P. Kutishenko1M. L. Ginzburg2A. M. Malysheva3Yu. N. Polyanskaya4State Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia I.M. Sechenov First Moscow State Medical UniversityState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaLyubertsy District Hospital № 2, Moscow RegionState Research Center for Preventive Medicine, Ministry of Health and Social Development of RussiaState Research Center for Preventive Medicine, Ministry of Health and Social Development of Russia<p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented.</p>http://klinitsist.abvpress.ru/index.php/Klin/article/view/125antiplatelet agentsaspirinclopidogrelmyocardial infarctiondrug resistanceproton pump inhibitors
collection DOAJ
language Russian
format Article
sources DOAJ
author S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
spellingShingle S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
Klinicist
antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
author_facet S. Yu. Martsevich
N. P. Kutishenko
M. L. Ginzburg
A. M. Malysheva
Yu. N. Polyanskaya
author_sort S. Yu. Martsevich
title ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_short ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_full ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_fullStr ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_full_unstemmed ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: THE PROBLEM OF EFFICIENCY, SAFETY AND COMPLIANCE
title_sort antiplatelet therapy in patients with high risk of thrombotic events: the problem of efficiency, safety and compliance
publisher ABV-press
series Klinicist
issn 1818-8338
publishDate 2014-07-01
description <p>Evidence based medicine data on ability of antiplatelet, including dual antiplatelet, therapy to improve the life expectancy of patients with high risk of thrombotic complications, especially patients with acute myocardial infarction is presented in brief. The problem of choosing a drug and resistance was overcoming. Modern clinical guidelines on safe antiplatelet therapy are presented.</p>
topic antiplatelet agents
aspirin
clopidogrel
myocardial infarction
drug resistance
proton pump inhibitors
url http://klinitsist.abvpress.ru/index.php/Klin/article/view/125
work_keys_str_mv AT syumartsevich antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT npkutishenko antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT mlginzburg antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT ammalysheva antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
AT yunpolyanskaya antiplatelettherapyinpatientswithhighriskofthromboticeventstheproblemofefficiencysafetyandcompliance
_version_ 1725185651316359168

Similar Items